ResMed Inc. (RMD)

118.50
NYSE : Health Technology
Prev Close 118.09
Day Low/High 118.21 / 119.28
52 Wk Low/High 90.64 / 120.00
Avg Volume 700.90K
Exchange NYSE
Shares Outstanding 143.39M
Market Cap 16.93B
EPS 2.20
P/E Ratio 38.22
Div & Yield 1.48 (1.24%)

Latest News

Nucor, Wells Fargo, ResMed: 'Mad Money' Lightning Round

Nucor, Wells Fargo, ResMed: 'Mad Money' Lightning Round

Jim Cramer weighs in on Nucor, Wells Fargo, ResMed, Gulfport Energy, JD.com, Alibaba.

New Analysis Shows Sleep Apnea More Common In Americas Than Previously Thought

New Analysis Shows Sleep Apnea More Common In Americas Than Previously Thought

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research...

ResMed Announces Participation In The 40th Annual Goldman Sachs Global Healthcare Conference

ResMed Announces Participation In The 40th Annual Goldman Sachs Global Healthcare Conference

ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will participate in a fireside chat discussion at the 40 th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019, beginning at...

ResMed Announces Participation In The 39th Annual William Blair Growth Stock Conference

ResMed Announces Participation In The 39th Annual William Blair Growth Stock Conference

ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39 th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.

ResMed Study Finds CPAP Adherence Improved By Remote Monitoring, Self-Monitoring Across 3 Countries

ResMed Study Finds CPAP Adherence Improved By Remote Monitoring, Self-Monitoring Across 3 Countries

Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD) (ASX: RMD) at the American Thoracic Society's 2019 ATS International Conference.

Age, Gender, Disease Severity Impact Adherence To Long-Term PAP Therapy More Than Previously Thought

Age, Gender, Disease Severity Impact Adherence To Long-Term PAP Therapy More Than Previously Thought

ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thoracic Society's ATS 2019 International Conference.

ResMed Elects Jan De Witte To Its Board Of Directors

ResMed Elects Jan De Witte To Its Board Of Directors

ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital SaaS solutions, today announced it has elected experienced business executive Jan De Witte to its board of directors.

Brightree Announces Access To CommonWell Health Alliance Network For Home Health And Hospice Customers

Brightree Announces Access To CommonWell Health Alliance Network For Home Health And Hospice Customers

Brightree ® today announced plans for its Home Health and Hospice customers to access more than 50,000 provider locations and health systems nationwide via the CommonWell Health Alliance, a nonprofit national trade association of health IT companies, and...

ResMed Inc. Announces Results For The Third Quarter Of Fiscal Year 2019

ResMed Inc. Announces Results For The Third Quarter Of Fiscal Year 2019

ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended March 31, 2019.

ResMed To Report Third Quarter Fiscal 2019 Earnings On May 2, 2019

ResMed To Report Third Quarter Fiscal 2019 Earnings On May 2, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.

AirFit P30i Nasal Pillows Tube-up CPAP Mask, Side View (Photo: Business Wire)

AirFit P30i Nasal Pillows Tube-up CPAP Mask, Side View (Photo: Business Wire)

ResMed (NYSE: RMD, ASX: RMD) today introduced its second top-of-head-connected CPAP mask for treating sleep apnea, a new nasal pillows option, AirFit P30i.

Brightree ReSupply Solution Expands Beyond Sleep To 3 More Disease Segments

Brightree ReSupply Solution Expands Beyond Sleep To 3 More Disease Segments

Brightree ® today announced that its Brightree ReSupply solution for home medical equipment (HME) providers has expanded to support additional categories outside of sleep therapy, including incontinence, diabetic, and enteral segments.

Brightree Introduces First-of-its-kind Analytics Suite For HMEs

Brightree Introduces First-of-its-kind Analytics Suite For HMEs

Brightree ® today introduced Advanced Analytics, the first analytics platform for HMEs that highlights workflow insights, KPI tracking, and peer benchmarking, without requiring users to aggregate data themselves.

ResMed Launches Next-generation ReSupply Solution

ResMed Launches Next-generation ReSupply Solution

ResMed (NYSE: RMD) (ASX: RMD) today launched its automated ResMed ReSupply solution for all U.

ResMed To Host An Investor Meeting On April 4, 2019

ResMed To Host An Investor Meeting On April 4, 2019

ResMed (NYSE: RMD) (ASX: RMD) today announced it will host an investor meeting on Thursday, April 4 th to discuss the Company's recent acquisitions, existing joint ventures and strategy pertaining to respiratory care and out-of-hospital software.

ResMed Acquires HB Healthcare To Help Millions Of Koreans Living With Sleep Apnea, Other Respiratory Conditions

ResMed Acquires HB Healthcare To Help Millions Of Koreans Living With Sleep Apnea, Other Respiratory Conditions

ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with...

Brightree Announces Enhanced Pharmacy Suite

Brightree Announces Enhanced Pharmacy Suite

Brightree ® today announced a new pharmacy suite for home infusion therapy providers and home medical equipment (HME) pharmacies to help them optimize business processes, more easily meet compliance requirements and provide the highest quality patient...

ResMed And Fisher & Paykel Healthcare Announce Settlement Of Global Patent Infringement Litigation

ResMed And Fisher & Paykel Healthcare Announce Settlement Of Global Patent Infringement Litigation

ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venues around the world.

ResMed Becomes #164 Most Shorted S&P 500 Component, Replacing L3 Technologies

ResMed Becomes #164 Most Shorted S&P 500 Component, Replacing L3 Technologies

The most recent short interest data has been released for the 01/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

ResMed Tanks on Second-Quarter Revenue Miss

ResMed Tanks on Second-Quarter Revenue Miss

The company easily beats earnings expectations, but falls short on revenue.

ResMed Inc. Announces Results For The Second Quarter Of Fiscal Year 2019

ResMed Inc. Announces Results For The Second Quarter Of Fiscal Year 2019

ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended December 31, 2018.

AirFit N30i Nasal CPAP Mask, Side View (Photo: Business Wire)

AirFit N30i Nasal CPAP Mask, Side View (Photo: Business Wire)

ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer's nose.

ResMed Mobi Portable Oxygen Concentrator (Photo: Business Wire)

ResMed Mobi Portable Oxygen Concentrator (Photo: Business Wire)

ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely available in the United States.

Safeguard Scientifics Partner Company Propeller Health Acquired By ResMed

Safeguard Scientifics Partner Company Propeller Health Acquired By ResMed

Safeguard to realize $41.4 million in cash proceeds, representing an approximate 3x cash-on-cash return and 34% IRR

ResMed Completes $225 Million Acquisition Of Propeller Health

ResMed Completes $225 Million Acquisition Of Propeller Health

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing...

ResMed To Report Second Quarter Fiscal 2019 Earnings On January 24, 2019

ResMed To Report Second Quarter Fiscal 2019 Earnings On January 24, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2019 on Thursday, January 24, 2019, after the New York Stock Exchange closes.

ResMed Becomes #249 Most Shorted S&P 500 Component, Replacing Invesco

ResMed Becomes #249 Most Shorted S&P 500 Component, Replacing Invesco

The most recent short interest data has been released for the 12/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Brightree Acquires Mobile Delivery Provider Apacheta To Streamline HME Delivery

Brightree Acquires Mobile Delivery Provider Apacheta To Streamline HME Delivery

Brightree, a leading provider of cloud-based software helping out-of-hospital providers improve business performance and patient outcomes, today announced it has acquired privately held mobile delivery and cloud-based software-as-a-service (SaaS) provider...

TheStreet Quant Rating: A- (Buy)